Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Huhn

Showing results (311-320 of 380) with videos related to

Pageof 38
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2013
Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patientsAimee C Hodowanec, Kirsten E Brady, Weihua Gao, et al.
International Journal of Cancer|May 8, 2000
Applicability of an absolute quantitative procedure to monitor intra-individual bcr/abl transcript kinetics in clinical samples from chronic myelogenous leukemia patientsK A Kreuzer, U Lass, S Nagel, et al.
Blood|October 15, 1993
Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomasH H Gerhartz, M Engelhard, P Meusers, et al.
Blood|January 15, 1996
Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteersR D Huhn, E Radwanski, S M O'Connell, et al.
Cellular Immunology|April 10, 1996
Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cellsI G Schmidt-Wolf, P Lefterova, V Johnston, et al.
European Journal of Haematology|September 1, 1996
Analysis of the p53 and MDM-2 gene in acute myeloid leukemiaB Seliger, S Papadileris, D Vogel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSFM Engelhard, H Gerhartz, G Brittinger, et al.
European Journal of Medical Research|January 16, 1999
Sensitivity and specificity of indirect immunofluorescence and Grocott-technique in comparison with immunocytology (alkaline phosphatase anti alkaline phosphatase = APAAP) for the diagnosis of Pneumocystis carinii in broncho-alveolar lavage (BAL)K N Arastéh, V Simon, R Musch, et al.
Journal of Virology|February 1, 1992
Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral bloodT F Schwarz, S Serke, B Hottenträger, et al.
Gene Therapy|April 16, 1998
Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+ CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 geneS Finke, B Trojaneck, P Lefterova, et al.
Pageof 38

Showing results (311-320 of 380) with videos related to

Sort By:
Pageof 38
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2013
Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patientsAimee C Hodowanec, Kirsten E Brady, Weihua Gao, et al.
International Journal of Cancer|May 8, 2000
Applicability of an absolute quantitative procedure to monitor intra-individual bcr/abl transcript kinetics in clinical samples from chronic myelogenous leukemia patientsK A Kreuzer, U Lass, S Nagel, et al.
Blood|October 15, 1993
Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomasH H Gerhartz, M Engelhard, P Meusers, et al.
Blood|January 15, 1996
Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteersR D Huhn, E Radwanski, S M O'Connell, et al.
Cellular Immunology|April 10, 1996
Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cellsI G Schmidt-Wolf, P Lefterova, V Johnston, et al.
European Journal of Haematology|September 1, 1996
Analysis of the p53 and MDM-2 gene in acute myeloid leukemiaB Seliger, S Papadileris, D Vogel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSFM Engelhard, H Gerhartz, G Brittinger, et al.
European Journal of Medical Research|January 16, 1999
Sensitivity and specificity of indirect immunofluorescence and Grocott-technique in comparison with immunocytology (alkaline phosphatase anti alkaline phosphatase = APAAP) for the diagnosis of Pneumocystis carinii in broncho-alveolar lavage (BAL)K N Arastéh, V Simon, R Musch, et al.
Journal of Virology|February 1, 1992
Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral bloodT F Schwarz, S Serke, B Hottenträger, et al.
Gene Therapy|April 16, 1998
Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+ CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 geneS Finke, B Trojaneck, P Lefterova, et al.
Pageof 38